Here are five details:
1. For the quarter, the company generated $35.8 million in revenue, a 13 percent increase year over year. U.S. revenue reached $31.7 million, a 12 percent jump year-over-year.
2. SeaSpine’s spinal implants segment generated $17.3 million in revenue for the quarter, a 12 percent increase year-over-year.
3. Within the orthobiologics segment, SeaSpine reported $18.5 million, a 13 percent increase year-over-year.
4. The company’s orthobiologics growth was attributed to recently launched products, including the OsteoStrand Plus, along with higher sales in demineralized bone matrix products.
5. SeaSpine expects its full-year revenue to range between $141 million and $142 million, representing a 7 percent to 8 percent increase year-over-year.
To read the full report, click here.
More articles on devices and implants:
DePuy Synthes to outsource production, closes manufacturing plant: 5 things to know
Wishbone Medical makes acquisition
Joimax moves into bigger US headquarters: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
